Alli 60 mg Hard Capsules. Summary of Product Characteristics, Haleon UK Trading Limited, 25 Apr. 2023, www.medicines.org.uk/emc/product/6533/smpc.
Weight loss tablets available from Voy

Side effects of weight loss tablets
Weight loss tablets vs injections
| Tablets | vs | Injections |
Tablet or capsule, with water | vs | Injection via pre-filled pen |
Once or up to 3 times a day, depending on treatment | vs | Weekly |
Wegovy Pill, Foundayo, Orlistat | vs | Wegovy, Mounjaro |
Prefer not to inject, want a daily routine | vs | Comfortable self-injecting, want less frequent dosing |
From £58/month | vs | From £64/month |

How do weight loss tablets work?
Weight loss tablets work in different ways depending on the medication. Wegovy Pill and Foundayo are GLP-1s that reduce appetite and slow digestion, so you feel fuller for longer. Orlistat blocks some of the fat you eat from being absorbed.

What to expect in your first delivery
Your first delivery includes your medication and everything you need to begin your treatment safely at home.
- Wegovy Pill or Foundayo: 30 tablets, a 30-day supply
- Orlos: 84 capsules, a 28-day supply
- Treatment plan: your treatment details at a glance
- Rescue pack (Wegovy Pill and Foundayo only): medication for sickness and diarrhoea, ready if you need it

How to order weight loss tablets
1. Complete your online assessment
Answer a few questions about your weight, goals and medical history. We'll recommend the treatment that fits.
2. Choose your plan
Select your plan length and medication. Your clinician will confirm the right starting dose for you.
3. Delivered within 1 working day
Once approved, your medication and everything you need to get started arrive in discreet packaging.
4. Ongoing clinical support
Track your progress and connect with your clinical team through the Voy app. Message or call whenever you need support.
















Our medical leadership
.webp&w=3840&q=75)
Dr. Earim Chaudry is a highly accomplished digital health doctor with extensive experience in the field of online and telemedicine-based healthcare. Over the years, he has played a pivotal role in shaping the landscape of digital healthcare in the UK.
Chief Medical Officer

Helen is passionate about building and scaling clinical services that embed innovation, quality care and clinical safety at their core. With a career spanning the NHS, femtech and digital health, she has consistently kept the bigger picture in view - thinking not just about individual patients, but about the populations they belong to.
Head of Clinical Services

Katy Jackson is an experienced healthcare leader with over 25 years of experience across the NHS and private healthcare sector. Katy has held senior leadership roles including Chief Operating Officer, Chief Pharmacist, and most recently Chief Clinical Officer for the UK’s largest menopause service.
Clinical Director - Women's Health
In partnership with leading educational and research institutions
Voy weight loss tablets: frequently asked questions
Dr Earim Chaudry (MBBS), Chief Medical Officer
Medically reviewed on August 27th, 2026.
Eli Lilly and Company. "Lilly's Oral GLP-1, Orforglipron, Demonstrated Meaningful Weight Loss and Cardiometabolic Improvements in Complete ATTAIN-1 Results Published in The New England Journal of Medicine." Eli Lilly and Company Investor Relations, 16 Sept. 2025, lilly.gcs-web.com/news-releases/news-release-details/lillys-oral-glp-1-orforglipron-demonstrated-meaningful-weight.
Foundayo 14.5 mg Film-Coated Tablets. Summary of Product Characteristics, Eli Lilly and Company Limited, 14 Aug. 2026, www.medicines.org.uk/emc/product/102531/smpc.
Lose weight & keep it off with our weight loss plans



















